Evaluation of the Pain Relief Effect of Battlefield Acupuncture on Patients with Chronic Low Back Pain Due to Lumbar Spine Degeneration.
Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Mar 7, 2025
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to relieve chronic lower back pain caused by lumbar spine degeneration, a common issue affecting many people. The trial will explore the effects of Battlefield Acupuncture (BFA), combined with electroacupuncture and pain medications, to see if it helps patients feel better. Lower back pain is a significant health concern worldwide, and this study aims to provide effective treatment options for those suffering in Vietnam.
To be eligible for the study, participants must be at least 20 years old, have been diagnosed with lumbar spine degeneration, and have experienced continuous back pain for at least three months. They should also be open to trying acupuncture and not have any severe medical conditions that could interfere with the study. If you join the trial, you can expect to receive a combination of acupuncture treatments and medications aimed at reducing your pain. This study hopes to find new ways to help people manage their back pain more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 20 years and older.
- • Patients diagnosed with lumbar spine degeneration (Imaging and clinical criteria according to the "Guidelines for Diagnosis and Treatment of Musculoskeletal Diseases" - Ministry of Health of Viet Nam 2014; AAFP-2024).
- • Patients with back pain with a VAS score of ≥ 50mm, continuous or recurrent with the same initial diagnosed cause, lasting from the time of initial diagnosis to the time of study participation for ≥ 3 months.
- • Individuals who have never used auricular acupuncture.
- • Voluntarily agree to participate in the study.
- Exclusion Criteria:
- • Individuals with cognitive disorders (Glasgow \< 13 points).
- • Individuals are allergic to any component of the ear acupressure seeds, or experiencing anxiety, fear of needles, or with a history of acupuncture syncope.
- • Patients with symptoms of saddle anesthesia, urinary or fecal incontinence, paresthesia or muscle atrophy, progressive muscle weakness.
- • History of cancer or currently undergoing cancer treatment, or unexplained weight loss.
- • Patients who are awakened at night due to back pain.
- • Patients contraindicated the medication used in the study: paracetamol.
- • Pregnant or breastfeeding women.
- • Patients are currently experiencing systemic infection.
- • Individuals with unhealed wounds, ear or lumbar region infections.
- • Currently participating in an intervention study with another drug or device.
About University Of Medicine And Pharmacy At Ho Chi Minh City
The University of Medicine and Pharmacy at Ho Chi Minh City is a premier academic institution dedicated to advancing healthcare education and research in Vietnam. Renowned for its commitment to excellence in medical training, the university actively engages in innovative clinical trials aimed at improving patient outcomes and addressing pressing health challenges. By leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the institution fosters collaboration between researchers, clinicians, and industry partners, ensuring the translation of scientific discoveries into effective medical practices. Through its rigorous ethical standards and dedication to patient safety, the university plays a vital role in enhancing the quality of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported